Mylan, Akorn, Astex Pharma, and Forest Laboratories Under StockCall's Microscope

    Mylan, Akorn, Astex Pharma, and Forest Laboratories Under StockCall's
                                  Microscope

PR Newswire

LONDON, April 8, 2013

LONDON, April 8, 2013 /PRNewswire/ --

A major trend to emerge in the healthcare industry since last year has been
the expiration of patents on several blockbuster drugs. The trend has
benefited companies such as Mylan Inc. (NASDAQ: MYL), and Akorn Inc. (NASDAQ:
AKRX), which focus generic drugs. For major drug manufacturers such as Astex
Pharmaceuticals Inc. (NASDAQ: ASTX), and biotechnology companies such as
Forest Laboratories Inc. (NYSE: FRX), increasing generic competition is a
major concern. Meanwhile, the healthcare industry is also evaluating the
impact of President Obama's Affordable Care Act (ACA), which was upheld by the
Supreme Court last year. Healthcare stocks ended on a mixed note on Friday as
the broad market struggled following dismal jobs report for the month of
March. StockCall has released full comprehensive research on MYL, AKRX, ASTX,
and FRX and these free technical analyses can be downloaded by signing up at

http://www.stockcall.com/technicalanalysis

Shares of Mylan Inc. ended nearly flat in Friday's trading session. The stock
traded between $28.20 and $28.66 before finishing the day 0.03% lower at
$28.63. Mylan's shares have had a decent run so far in 2013, gaining more than
4%. However, the stock has struggled in the last two weeks after failing to
break through $31 resistance level. The company's shares have seen a series of
lows over the past two weeks, which is a bearish signal. The downbeat trend is
further confirmed by the stock's MACD chart. The stock has also slipped below
its 50-day moving average. Free technical analysis on MYL available by signing
up at

http://www.StockCall.com/MYL040813.pdf

Akorn Inc.'s shares ended flat in Friday's trading session. The stock traded
between $13.25 and $13.51 before finishing the day at $13.50. Akorn's shares
last week slipped below their 200-day moving average, which is a bearish
signal. The stock's MACD has also slipped below the signal line, further
confirming the negative trend. The company's shares currently have support at
around $13.25. Year-to-date, the stock has gained more than 1%. Register today
and access the free research on AKRX at

http://www.StockCall.com/AKRX040813.pdf

Shares of Astex Pharmaceuticals Inc. rose sharply in trading on Friday even as
the broad market struggled. The stock touched an intra-day high of $5.49
before finishing the day 3.06% higher at $5.39. Astex Pharma's shares are
currently trading close to their 52-week high of $5.81. The stock has gained
more than 6.70% in the last three sessions. Year-to-date, the company's shares
have gained more than 85%, easily outperforming the broad market. The stock
has seen a series of highs over the past two weeks, which is a bullish signal.
The free report on ASTX can be downloaded by signing up now at

http://www.StockCall.com/ASTX040813.pdf

Shares of Forest Laboratories Inc. edged lower on Friday, tracking losses in
the broad market. The stock ended the day 0.37% lower at $37.52 after touching
an intra-day low of $37.08. Shares of FRX have traded sideways in the last few
weeks, struggling to break through $38 resistance level. The stock is
currently trading above its 50-day and 200-day moving averages, which is a
bullish signal. However, the stock's MACD chart suggests that market sentiment
has turned bearish. Year-to-date, the stock has gained more than 6.20%. Free
report on FRX can be accessed by registering at

http://www.StockCall.com/FRX040813.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise
and comprehensive research and opinions on stocks making the headlines. Sign
up today to talk to our financial analyst at

http://www.stockcall.com 

SOURCE StockCall.com

Contact: Contact Person: William T. Knight, Email: info@stockcall.com, Contact
Number: +1(646) 396-9857 (9:00 am EST – 01:30 pm EST)
 
Press spacebar to pause and continue. Press esc to stop.